#HealthCanada; #JohnsonAndJohnsonCOVID19Vaccine; #Jansen
Ottawa/Canadian-Media: Johnson & Johnson's COVID-19 vaccine produced by the U.S. pharmaceutical subsidiary, Janssen Inc. is the fourth to receive approval from Health Canada for use in Canada, the first that requires only a single dose and easy storage and can be used for adults aged 18 and older, Health Canada reported.
Johnson & Johnson covid-19 vaccine. Image credit: Facebook page
"As with all COVID-19 vaccines, Health Canada authorized the Janssen one after an independent and thorough scientific review for safety, efficacy, and quality," Dr. Supriya Sharma, Health Canada's chief medical adviser, told a media briefing in Ottawa today.
"After assessing all the data, we concluded there was strong evidence that showed the benefits of this vaccine outweigh the potential risks."
With its efficacy rate of 66.9 percent, much less compared to 90 percent with previously approved vaccines, Sharma said the shot offers strong protection against the threats that matter most: serious illness, hospitalizations, and death.
"While each of the vaccines Health Canada has authorized has different efficacy numbers, the reality is that you will have a greatly reduced chance of getting COVID-19 with any of the ... vaccines that have been authorized," said Sharma.
Canada has ordered 10 million doses from Johnson & Johnson, with options for up to 28 million more, with the full order of 10 million should be delivered by September, said Joëlle Paquette, director-general for vaccines at Public Services and Procurement Canada yesterday.
"At the moment, we are still in discussion with Johnson and Johnson to determine where their doses will be coming from and the delivery schedule," Paquette said.